Company name
2022Founder
Maze Therapeutics develops precision medicines for common diseases with large unmet medical needs, using its Compass platform and genetic insights. Its programs focus on kidney disease, including APOL1-mediated kidney disease, chronic kidney disease, and phenylketonuria.